Background: Enteroviruses (EV) are a large group of Picornaviruses associated with respiratory, gastrointestinal, and neurologic symptoms in the immunocompetent host. Little is known about the epidemiologic and clinical impact in pediatric hematologic/oncologic patients.
Procedure: From 2001 through 2017, different clinical specimens were collected from pediatric hematologic/oncologic patients and were tested for enteroviral RNA.
Results: Of 13 004 specimens collected from 761 patients, 38 (0.3%) obtained from 14 patients (1.8%) tested positive for EV RNA. Viral shedding was observed without viremia and vice versa. None of 80 cerebrospinal fluid specimens obtained from 60 patients with neurologic symptoms were positive for EV RNA. None of 14 patients positive for EV RNA showed EV-specific symptoms. In 11/14 patients, EV RNA was found to be negative in the follow-up specimen. The remaining patient with a severe primary immune deficiency showed repeated positive EV RNA results for >5 years.
Conclusions: In this pediatric hematologic/oncologic cohort, EV infection occurred rarely and without related symptoms. Specimens concurrently obtained from one patient are commonly not in accordance with each other. In the vast majority of patients, EV RNA appears to turn negative in the follow-up specimen. EV infections seem to have a low impact in this patient cohort.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pbc.27448 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sepsis Education and Successful Implementation of a Sepsis Recognition and Management Workflow in an Inpatient Pediatric Hematologic Oncologic Unit.
J Pediatr Hematol Oncol Nurs
December 2024
Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Sepsis is a leading cause of morbidity, mortality, and healthcare utilization for children worldwide. Forty-nine percent of pediatric sepsis patients have an underlying condition rendering them more susceptible to infection. One in six severe sepsis patients has an underlying neoplastic disease and has a 30% higher risk of death compared to other severe sepsis patients.
View Article and Find Full Text PDFExploring atypical manifestations and multisystem involvement of Epstein-Barr virus infection in hospitalized pediatric patients from Mexico: insights from a tertiary hospital (2012-2022).
Bol Med Hosp Infant Mex
October 2024
Unidad de Investigación en Virología y Cáncer, Hospital Infantil de México "Federico Gómez".
Article Synopsis
- - The Epstein-Barr virus (EBV) affects over 95% of people globally, typically causing infectious mononucleosis in children, yet it can also present with unusual and severe symptoms in a clinical setting, particularly in a pediatric hospital in Mexico.
- - A study reviewed medical records of 26 EBV-positive patients under 18 years from 2012-2022, revealing that common symptoms included fever (85%) and lymphadenopathy (35%), with 65% experiencing severe atypical complications like pneumonia and blood disorders, leading to some fatalities.
- - The findings highlight the importance of recognizing EBV as a possible cause of varied and serious clinical symptoms in children, stressing the need for thorough assessments and increased
Patterns of Multiple Organ Dysfunction and Renal Recovery in Critically Ill Children and Young Adults Receiving Continuous Renal Replacement Therapy.
Crit Care Explor
May 2024
Division of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
Objectives: Acute kidney injury requiring dialysis (AKI-D) commonly occurs in the setting of multiple organ dysfunction syndrome (MODS). Continuous renal replacement therapy (CRRT) is the modality of choice for AKI-D. Mid-term outcomes of pediatric AKI-D supported with CRRT are unknown.
View Article and Find Full Text PDFResults of a long-term, prospective study on complications of central venous catheter in pediatric patients with hematologic-oncologic diseases.
Pediatr Blood Cancer
July 2024
Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Article Synopsis
- - The study examined complications related to central venous catheters (CVCs) in children with hematologic-oncologic diseases, discovering a total of 671 complications recorded over 153,731 CVC days, averaging 4.365 complications per 1000 CVC days.
- - Key findings indicated that nearly half of all complications were due to malfunctions, followed by bacteremia and mechanical issues, with various CVC types significantly affecting the risk levels.
- - The research concluded that around 20-25% of long-term CVCs are prematurely removed, underlining the need for ongoing monitoring to better manage CVCs and reduce complications in pediatric patients.
Granulocyte transfusions in life-threatening infections of children with hemato-oncological diseases.
Transfus Apher Sci
June 2024
Department of Pediatric Hematology and Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Granulocytes are the most important cells for host defense during infections. Granulocyte suspension transfusions (GTx) may be given as additional treatment in severely neutropenic patients with life-threatening infections when antimicrobial therapy is inadequate. The aim of this study was to evaluate the effectiveness and safety of GTx for the treatment of children with hemato-oncological disease, febrile neutropenia and serious life-threatening infections.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!